Polycystic kidney disease screening: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 4: Line 4:
==Overview==
==Overview==
==Screening==
==Screening==
There is insufficient evidence to recommend routine screening for [disease/malignancy].
OR
According to the [guideline name], screening for [disease name] is not recommended.
OR
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with:
*[Condition 1]
*[Condition 2]
*[Condition 3]
*[[Ultrasonography]] has been used to screen those with a family history of polycystic kidney disease
*[[Ultrasonography]] has been used to screen those with a family history of polycystic kidney disease
*[[Serum creatinine]], [[urinalysis]] and regular [[blood pressure]] measurements can also be implemented to test in these patients <ref name="pmid20219617">{{cite journal |author=Pei Y, Watnick T |title=Diagnosis and screening of autosomal dominant polycystic kidney disease |journal=[[Advances in Chronic Kidney Disease]] |volume=17 |issue=2 |pages=140–52 |year=2010 |month=March |pmid=20219617 |pmc=2841025 |doi=10.1053/j.ackd.2009.12.001 |url=}}</ref> <ref name="pmid3545099">{{cite journal |author=Taitz LS, Brown CB, Blank CE, Steiner GM |title=Screening for polycystic kidney disease: importance of clinical presentation in the newborn |journal=[[Archives of Disease in Childhood]] |volume=62 |issue=1 |pages=45–9 |year=1987 |month=January |pmid=3545099 |pmc=1778152 |doi= |url=}}</ref>
*[[Serum creatinine]], [[urinalysis]] and regular [[blood pressure]] measurements can also be implemented to test in these patients <ref name="pmid20219617">{{cite journal |author=Pei Y, Watnick T |title=Diagnosis and screening of autosomal dominant polycystic kidney disease |journal=[[Advances in Chronic Kidney Disease]] |volume=17 |issue=2 |pages=140–52 |year=2010 |month=March |pmid=20219617 |pmc=2841025 |doi=10.1053/j.ackd.2009.12.001 |url=}}</ref> <ref name="pmid3545099">{{cite journal |author=Taitz LS, Brown CB, Blank CE, Steiner GM |title=Screening for polycystic kidney disease: importance of clinical presentation in the newborn |journal=[[Archives of Disease in Childhood]] |volume=62 |issue=1 |pages=45–9 |year=1987 |month=January |pmid=3545099 |pmc=1778152 |doi= |url=}}</ref>

Revision as of 20:19, 4 June 2018

Polycystic kidney disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Polycystic kidney disease from other Diseases

Epidemiology and Demographics

Risk Factor

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Future or Investigational Therapies

Case Studies

Case #1

Polycystic kidney disease screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Polycystic kidney disease screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Polycystic kidney disease screening

CDC on Polycystic kidney disease screening

Polycystic kidney disease screening in the news

Blogs on Polycystic kidney disease screening

Directions to Hospitals Treating Polycystic kidney disease

Risk calculators and risk factors for Polycystic kidney disease screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2]

Overview

Screening

There is insufficient evidence to recommend routine screening for [disease/malignancy].

OR

According to the [guideline name], screening for [disease name] is not recommended.

OR

According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with:

  • [Condition 1]
  • [Condition 2]
  • [Condition 3]

References

  1. Pei Y, Watnick T (2010). "Diagnosis and screening of autosomal dominant polycystic kidney disease". Advances in Chronic Kidney Disease. 17 (2): 140–52. doi:10.1053/j.ackd.2009.12.001. PMC 2841025. PMID 20219617. Unknown parameter |month= ignored (help)
  2. Taitz LS, Brown CB, Blank CE, Steiner GM (1987). "Screening for polycystic kidney disease: importance of clinical presentation in the newborn". Archives of Disease in Childhood. 62 (1): 45–9. PMC 1778152. PMID 3545099. Unknown parameter |month= ignored (help)

Template:WH Template:WS